Sébastien Debarbieux
Sébastien Debarbieux is an expert in Dermatology at Centre Hospitalier Lyon Sud (France). Sébastien Debarbieux has authored 156 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 359 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Immunology - Public Health - Hematology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 156
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Incidence and Mortality of Mucous Membrane Pemphigoid in France. PMID 42114084 — mortality, syphilis, incidence, ear, pemphigoid, bullous, nose, mucous membrane, dermatology, membranes | Br J Dermatol | 2026 | 0 |
| Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors. PMID 39908046 — antibodies, adrenal cortex hormones, cohort studies, skin diseases, rituximab, therapeutics, pemphigus | JAMA Dermatol | 2025 | 5 |
| Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris. PMID 40042819 — safety, skin diseases, rituximab, pemphigus | JAMA Dermatol | 2025 | 0 |
| Delayed panniculitis post cytoreductive surgery and intraperitoneal chemotherapy with mitomycin C. PMID 41058207 — sexually transmitted diseases, mitomycin, cytoreduction surgical procedures, hyperthermia, induced, hyperthermic intraperitoneal chemotherapy, drug therapy, skin diseases, panniculitis, chemotherapy | J Eur Acad Dermatol Venereol | 2025 | 0 |
| Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial. PMID 38265821 — adrenal cortex hormones, follow-up studies, skin diseases, therapeutics, prednisone, safety, enzyme-linked immunosorbent assay, disease-free survival, pemphigus, rituximab | JAMA Dermatol | 2024 | 8 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map